Literature DB >> 10861028

Cutting edge: differential expression of chemokines in Th1 and Th2 cells is dependent on Stat6 but not Stat4.

S Zhang1, N W Lukacs, V A Lawless, S L Kunkel, M H Kaplan.   

Abstract

The in vivo function of Th cell subsets is largely dependent on the ability of differentiated CD4+ T cells to be recruited to specific sites and secrete restricted sets of cytokines. In this paper we demonstrate that Th1 and Th2 cells secrete discrete patterns of chemokines, small m.w. cytokines that function as chemoattractants in inflammatory reactions. Th2 cells secrete macrophage-derived chemokine and T cell activation gene 3, and acquisition of this pattern of expression is dependent on Stat6. In contrast, Th1 cells secrete lymphotactin and RANTES, though unlike IFN-gamma, expression of these chemokines is independent of Stat4. We further show that supernatants from activated Th2 cells preferentially induce the chemotaxis of Th2 over Th1 cells, corresponding with Stat6-dependent expression of CCR4 and CCR8 in Th2 cells. These data provide the basis for restricted and direct T cell-mediated cellular recruitment to sites of inflammation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10861028     DOI: 10.4049/jimmunol.165.1.10

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

1.  Effect of targeted disruption of STAT4 and STAT6 on the induction of experimental autoimmune encephalomyelitis.

Authors:  T Chitnis; N Najafian; C Benou; A D Salama; M J Grusby; M H Sayegh; S J Khoury
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

Review 2.  JAK-STAT signaling in asthma.

Authors:  Alessandra B Pernis; Paul B Rothman
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

Review 3.  Jaks, STATs, Cytokines, and Sepsis.

Authors:  Melanie J Scott; Christopher J Godshall; William G Cheadle
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

4.  T-bet concomitantly controls migration, survival, and effector functions during the development of Valpha14i NKT cells.

Authors:  Jennifer L Matsuda; Qianjun Zhang; Rachel Ndonye; Stewart K Richardson; Amy R Howell; Laurent Gapin
Journal:  Blood       Date:  2005-12-15       Impact factor: 22.113

5.  Conditional ablation of macrophages halts progression of crescentic glomerulonephritis.

Authors:  Jeremy S Duffield; Peter G Tipping; Tiina Kipari; Jean-François Cailhier; Spike Clay; Richard Lang; Joseph V Bonventre; Jeremy Hughes
Journal:  Am J Pathol       Date:  2005-11       Impact factor: 4.307

6.  STAT4 is required for antibacterial defense but enhances mortality during polymicrobial sepsis.

Authors:  C J Godshall; A B Lentsch; J C Peyton; M J Scott; W G Cheadle
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

7.  Patterns of chemokine expression in models of Schistosoma mansoni inflammation and infection reveal relationships between type 1 and type 2 responses and chemokines in vivo.

Authors:  M K Park; K F Hoffmann; A W Cheever; D Amichay; T A Wynn; J M Farber
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

8.  Production of TARC and MDC by naive T cells in asthmatic patients.

Authors:  Hirokuni Hirata; Masafumi Arima; Gang Cheng; Kyoko Honda; Fumiya Fukushima; Nozomi Yoshida; Fukiko Eda; Takeshi Fukuda
Journal:  J Clin Immunol       Date:  2003-01       Impact factor: 8.317

9.  Distinct requirements for the naturally occurring splice forms Stat4alpha and Stat4beta in IL-12 responses.

Authors:  Timothy Hoey; Shangming Zhang; Nathan Schmidt; Qing Yu; Shyam Ramchandani; Xiang Xu; Lisa K Naeger; Ya-Lin Sun; Mark H Kaplan
Journal:  EMBO J       Date:  2003-08-15       Impact factor: 11.598

10.  Differential production of macrophage inflammatory protein 1gamma (MIP-1gamma), lymphotactin, and MIP-2 by CD4(+) Th subsets polarized in vitro and in vivo.

Authors:  Kerstin Müller; Susanne Bischof; Frank Sommer; Michael Lohoff; Werner Solbach; Tamás Laskay
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.